Passage Bio Inc reports results for the quarter ended in June - Earnings Summary

Passage Bio

07/08/2023 14:32

* Passage Bio Inc  PASG.OQ  reported a quarterly adjusted
loss
of 44 cents​​ per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for a loss
of 48 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Passage Bio Inc's reported EPS for the quarter was a loss
of 44
cents​.
    * The mean earnings estimate of analysts had risen by
about 4% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Passage Bio Inc shares had fallen by 6.5% this quarter and
lost 36.2% so far this year.
    * The company reported a quarterly loss of $23.86 million.
    * Wall Street's median 12-month price target for Passage Bio
Inc
is $8.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.48          -0.44          Beat
 Mar. 31 2023      -0.50          -0.63          Missed
 Dec. 31 2022      -0.52          -0.49          Beat
 Sep. 30 2022      -0.79          -0.49          Beat